A Trial To Assess Safety And Tolerability Of PF-04691502 In Cancer Patients

NCT00927823 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
37
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer